Cobra provides GMP manufacture of virus and phage products following Good Manufacturing Practices of production and testing for all viral manufacturing programmes to ensure quality products for our customers’ preclinical and clinical trials through to commercial supply.
Processes are clearly defined, controlled and validated to ensure compliance, clear records are made, and any deviations are investigated and documented. We are able to provide a certificate of GMP compliance and GMP campaign summary report with QA review
of completed documentation.
To fulfil our customers' virus fill finish requirements, we have developed a key working relationship with Nova Laboratories
, an audited filling house utilising isolator systems, which is located an hour from Cobra’s virus manufacturing facility
All aseptic manufacturing projects meet rigorous sterility requirements and are expertly project managed
with detailed timeline planning and milestone tracking.